Related content

Does megestrol acetate down-regulate interleukin-6 in patients?

By Mantovani Giovanni  

Supportive Care in Cancer, Vol. 10, Iss. 7, 2002-10 ,pp. : 566-567

Springer Publishing Company

Access to resources Recommend Favorite

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial

By De Conno F.   Martini C.   Zecca E.   Balzarini A.   Venturino P.   Groff L.   Caraceni A.  

European Journal of Cancer, Vol. 34, Iss. 11, 1998-10 ,pp. : 1705-1709

Elsevier

Access to resources Recommend Favorite

Tamoxifen for one year versus two years versus 6 months of Tamoxifen and 6 months of megestrol acetate: A randomized comparison in postmenopausal patients with high-risk breast cancer (DBCG 89C)

By Andersen Jørn   Kamby Claus   Ejlertsen Bent   Cold Søren   Ewertz Marianne   Jacobsen Erik   Philip Preben   Møller Knud   Jensen Disa   Møller Susanne  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 718-724

Informa Healthcare

Access to resources Recommend Favorite

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial

By Westman G.   Bergman B.   Albertsson M.   Kadar L.   Gustavsson G.   Thaning L.   Andersson M.   Straumits A.   Jeppson B.   Linden   Ewers S.-B.   Andersson H.   Mercke C.   Hafstrom   Birck O.   Orgum P.  

European Journal of Cancer, Vol. 35, Iss. 4, 1999-04 ,pp. : 586-595

Elsevier

Access to resources Recommend Favorite

Supportive Use of Megestrol Acetate in Patients with Head and Neck Cancer During Radio(chemo)therapy

By Fietkau R.   Riepl M.   Kettner H.   Hinke A.   Sauer R.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 75-79

Elsevier

Access to resources Recommend Favorite